Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av FT Tech Tonic
Visa alla avsnitt av FT Tech TonicFT Tech Tonic med Financial Times finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
